Zealand Pharma A/S(ZEAL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ZEAL Zealand Pharma A/S

Post-Market Trading 09-19 17:47:47 EDT

17.59

+0.00

0.00%

High17.59	Low17.59	Vol0.00
Open17.59	D1 Closing17.59	Amplitude0.00%
Mkt Cap814.08M	Tradable Cap647.26M	Total Shares46.28M
T/O0.00	T/O Rate0.00%	Tradable Shares36.80M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ZEAL","market":"US","secType":"STK","nameCN":"Zealand Pharma A/S","latestPrice":17.59,"timestamp":1726776000000,"preClose":17.59,"halted":0,"volume":0,"delay":0,"floatShares":36796777,"shares":46280952,"eps":-3.854254,"marketStatus":"Post-Market Trading","change":0,"latestTime":"09-19 17:47:47 EDT","open":17.59,"high":17.59,"low":17.59,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.854254,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1726790400000},"marketStatusCode":4,"adr":1,"adrRate":1,"listingDate":1502251200000,"exchange":"NASDAQ","adjPreClose":17.59,"volumeRatio":0},"requestUrl":"/m/hq/s/ZEAL/tweets","defaultTab":"tweets","newsList":[{"id":"2466620409","title":"Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2466620409","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466620409?lang=en_us&edition=fundamental","pubTime":"2024-09-12 23:01","pubTimestamp":1726153260,"startTime":"0","endTime":"0","summary":"Copenhagen, Denmark, September 12, 2024 – Zealand Pharma A/S   , a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has increased its share capital by a nominal amount of DKK 10,110 divided into 10,110 new shares with a nominal value of DKK 1 each. The increase is a consequence of the exercise of warrants granted under several of Zealand Pharma's employee warrant programs. The increase is a consequence of the exercise of warrants granted undertwo of Zealand Pharma's employee warrant programs.The exercise price was DKK 224.40 per share for 3,977 of new shares and DKK 224.40 per share for 6,133 of new shares. The total proceeds to Zealand from the capital increase amount to DKK 2,268,684.00.The new shares give rights to dividend and other rights from the time of the warrant holder's exercise notice. Each new share carries one vote at Zealand Pharma’s general meetings. Zealand Pharma has only one class of shares.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/cgyYMo5QPKpW7CjArtwXjQ--~B/aD0yNDQ7dz02MDY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/76be332007740327e38ca6218ee6aa06","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/cgyYMo5QPKpW7CjArtwXjQ--~B/aD0yNDQ7dz02MDY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/76be332007740327e38ca6218ee6aa06"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zealand-pharma-increases-share-capital-150100409.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ZLDPF","BK4139","ZEAL"],"gpt_icon":0},{"id":"2466924151","title":"Zealand Pharma Weight Loss Treatment Trial Shows up to 8.3% Reduction in Body Weight","url":"https://stock-news.laohu8.com/highlight/detail?id=2466924151","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466924151?lang=en_us&edition=fundamental","pubTime":"2024-09-09 23:53","pubTimestamp":1725897180,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK4139","ZEAL"],"gpt_icon":0},{"id":"2466192454","title":"Zealand Pharma Weight Loss Treatment Trial Shows up to 8.3% Reduction in Body Weight","url":"https://stock-news.laohu8.com/highlight/detail?id=2466192454","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466192454?lang=en_us&edition=fundamental","pubTime":"2024-09-09 23:53","pubTimestamp":1725897180,"startTime":"0","endTime":"0","summary":"Zealand Pharma  said Monday that results from a phase 1b trial of the dapiglutide treatment showed the estimated mean body weight had declined by up to 8.3% on a placebo-corrected basis after 13 weekly doses.Dapiglutide was safe and well-tolerated in part 1 of the study, with no severe treatment-emergent adverse events and only one serious adverse event, which was not tied to the drug, the company said.Part 2 of the trial is assessing higher doses of dapiglutide up to 26 milligrams over a 28-week treatment period, with results expected in the first half of 2025.Zealand Pharma said it intends to advance the clinical development of dapiglutide into a phase 2b trial in people with overweight and obesity, with a launch expected in H1 2025.The company also expects to assess the potential of dapiglutide in select obesity-related comorbidities, it said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ZEAL","BK4139"],"gpt_icon":0},{"id":"2466927411","title":"Zealand Pharma Announces Positive Topline Results From 13-Week Phase 1B Multiple Ascending Dose Clinical Trial With Glp-1/Glp-2 Receptor Dual Agonist Dapiglutide","url":"https://stock-news.laohu8.com/highlight/detail?id=2466927411","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466927411?lang=en_us&edition=fundamental","pubTime":"2024-09-09 23:46","pubTimestamp":1725896802,"startTime":"0","endTime":"0","summary":"Zealand Pharma A/S :Zealand Pharma Announces Positive Topline Results From 13-Week Phase 1B Multiple Ascending Dose Clinical Trial With Glp-1/Glp-2 Receptor Dual Agonist Dapiglutide.Zealand Pharma A/S","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.trkd.thomsonreuters.com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZEAL"],"gpt_icon":0},{"id":"2463794557","title":"Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons","url":"https://stock-news.laohu8.com/highlight/detail?id=2463794557","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2463794557?lang=en_us&edition=fundamental","pubTime":"2024-08-31 04:00","pubTimestamp":1725048000,"startTime":"0","endTime":"0","summary":"Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons. Copenhagen, Denmark, August 30, 2024 – Zealand Pharma A/S   , a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has received information on transactions in Zealand's shares or related securities conducted by persons discharging managerial responsibilities and/or their closely associated persons and hereby publishes the information on such transactions.Zealand Pharma A/S   is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development agreements with a number of pharma companies as well as commercial partnerships for its markete","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/cgyYMo5QPKpW7CjArtwXjQ--~B/aD0yNDQ7dz02MDY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/76be332007740327e38ca6218ee6aa06","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/cgyYMo5QPKpW7CjArtwXjQ--~B/aD0yNDQ7dz02MDY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/76be332007740327e38ca6218ee6aa06"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/transactions-zealand-pharma-shares-related-200000184.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ZLDPF","ZEAL"],"gpt_icon":0},{"id":"2463875034","title":"Total number of shares and voting rights in Zealand Pharma on August 30, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2463875034","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2463875034?lang=en_us&edition=fundamental","pubTime":"2024-08-30 23:00","pubTimestamp":1725030000,"startTime":"0","endTime":"0","summary":"Copenhagen, Denmark, August 30, 2024 – Zealand Pharma A/S   , a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with section 32 of the Danish Capital Markets Act, announces the total number of shares and voting rights in the Company at the end of a calendar month during which there have been changes to its share capital.In Company announcement No. 41/2024 from August 22, 2024, Zealand announced an increase in share capital relating to exercise of employee warrants. Following this announcement, the table below lists the total number of shares and voting rights in Zealand up to and including August 30, 2024.Zealand Pharma A/S   is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The co","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/cgyYMo5QPKpW7CjArtwXjQ--~B/aD0yNDQ7dz02MDY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/76be332007740327e38ca6218ee6aa06","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/cgyYMo5QPKpW7CjArtwXjQ--~B/aD0yNDQ7dz02MDY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/76be332007740327e38ca6218ee6aa06"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/total-number-shares-voting-rights-150000284.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ZEAL","BK4139","ZLDPF","TSS"],"gpt_icon":0},{"id":"2461372736","title":"Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2461372736","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2461372736?lang=en_us&edition=fundamental","pubTime":"2024-08-23 04:00","pubTimestamp":1724356800,"startTime":"0","endTime":"0","summary":"Copenhagen, Denmark, August 22, 2024 – Zealand Pharma A/S   , a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has increased its share capital by a nominal amount of DKK 13,000 divided into 13,000 new shares with a nominal value of DKK 1 each. The increase is a consequence of the exercise of warrants granted undertwo of Zealand Pharma's employee warrant programs.The exercise price was DKK 224.40 per share for 3,000 of new shares under one employee warrant program and DKK 224.40 per share as well for 10,000 of new shares related to another employee warrant program. The total proceeds to Zealand from the capital increase amount to DKK 2,917,200.00.The new shares give rights to dividend and other rights from the time of the warrant holder's exercise notice. Each new share carries one vote at Zealand Pharma’s general meetings. Zealand Pharma has only one class of shares.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/cgyYMo5QPKpW7CjArtwXjQ--~B/aD0yNDQ7dz02MDY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/76be332007740327e38ca6218ee6aa06","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/cgyYMo5QPKpW7CjArtwXjQ--~B/aD0yNDQ7dz02MDY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/76be332007740327e38ca6218ee6aa06"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zealand-pharma-increases-share-capital-200000251.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ZEAL","BK4139","ZLDPF"],"gpt_icon":0},{"id":"2459494553","title":"ZEAL Network (0QJQ) Receives a Buy from Berenberg Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2459494553","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459494553?lang=en_us&edition=fundamental","pubTime":"2024-08-15 13:35","pubTimestamp":1723700153,"startTime":"0","endTime":"0","summary":"Berenberg Bank analyst James Letten maintained a Buy rating on ZEAL Network (0QJQ – Research Report) yesterday and set a price target of €48.00. Th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/zeal-network-0qjq-receives-a-buy-from-berenberg-bank?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/zeal-network-0qjq-receives-a-buy-from-berenberg-bank?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ZEAL"],"gpt_icon":0},{"id":"2456729649","title":"Warburg Research Sticks to Its Buy Rating for ZEAL Network (0QJQ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2456729649","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2456729649?lang=en_us&edition=fundamental","pubTime":"2024-08-03 09:35","pubTimestamp":1722648918,"startTime":"0","endTime":"0","summary":"Warburg Research analyst Marius Fuhrberg maintained a Buy rating on ZEAL Network (0QJQ – Research Report) on August 1 and set a price target of €59...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/warburg-research-sticks-to-its-buy-rating-for-zeal-network-0qjq?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/warburg-research-sticks-to-its-buy-rating-for-zeal-network-0qjq?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZEAL"],"gpt_icon":0},{"id":"2454803744","title":"Viking Therapeutics: Better-Than-Expected Trial Timelines While Pipeline Expands","url":"https://stock-news.laohu8.com/highlight/detail?id=2454803744","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2454803744?lang=en_us&edition=fundamental","pubTime":"2024-07-25 23:17","pubTimestamp":1721920664,"startTime":"0","endTime":"0","summary":"Viking Therapeutics, Inc. provided a better-than-expected pipeline update when it reported second quarter earnings.Subcutaneous VK2735 will advance straight into a phase 3 trial, and this should speed","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/88621650/image_88621650.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/88621650/image_88621650.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4706587-viking-therapeutics-better-than-expected-trial-timelines-while-pipeline-expands","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["RHHBY","LU0238689110.USD","LU0385154629.USD","LU1804176565.USD","BK4588","BK4139","LU0058720904.USD","LU0417517546.SGD","IE00BZ1G4Q59.USD","LU0079474960.USD","IE00B4R5TH58.HKD","LU0289739699.SGD","VKTX","LU0640476718.USD","IE00BFTCPJ56.SGD","BK4534","LU0471298777.SGD","IE00BJJMRZ35.SGD","03165","IE00BK4W5L77.USD","IE00BJT1NW94.SGD","BK4533","IE0009355771.USD","LU0122379950.USD","BK4585","LU0471298694.HKD","IE00BKVL7J92.USD","BK4532","LU1069344957.HKD","LU1551013342.USD","IE00B2B36J28.USD","LU0109391861.USD","LU1280957306.USD","LU0097036916.USD","LU0198837287.USD","IE00BJLML261.HKD","BK4516","LU0820561909.HKD","LU0256863811.USD","LU1023059063.AUD","GB00BDT5M118.USD","LU0096364046.USD","LU0823416689.USD","LU0154236417.USD","IE0002141913.USD","BK4581","ZEAL","LU0061475181.USD"],"gpt_icon":1},{"id":"2451164720","title":"ZEAL Network’s Strategic Moves and Financial Upswing Prompt Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2451164720","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2451164720?lang=en_us&edition=fundamental","pubTime":"2024-07-15 21:05","pubTimestamp":1721048749,"startTime":"0","endTime":"0","summary":"Jefferies analyst Henrik Paganetty maintained a Buy rating on ZEAL Network (0QJQ – Research Report) today and set a price target of €45.00. Henrik ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/zeal-networks-strategic-moves-and-financial-upswing-prompt-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/zeal-networks-strategic-moves-and-financial-upswing-prompt-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZEAL"],"gpt_icon":0},{"id":"2451644205","title":"ZEAL NETWORK SE : JEFFERIES RAISES TARGET PRICE TO EUR 45 FROM EUR 39","url":"https://stock-news.laohu8.com/highlight/detail?id=2451644205","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2451644205?lang=en_us&edition=fundamental","pubTime":"2024-07-15 20:46","pubTimestamp":1721047566,"startTime":"0","endTime":"0","summary":"ZEAL NETWORK SE : JEFFERIES RAISES TARGET PRICE TO EUR 45 FROM EUR 39","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240715:nFWN3J711E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ZLNWF","ZEAL"],"gpt_icon":0},{"id":"2438137555","title":"ZEAL NETWORK SE :Dividend Rises From Eur 1 To Eur 1.10 Per Share.","url":"https://stock-news.laohu8.com/highlight/detail?id=2438137555","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2438137555?lang=en_us&edition=fundamental","pubTime":"2024-05-28 20:11","pubTimestamp":1716898267,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.trkd.thomsonreuters.com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_live","symbols":["BK4139","ZLNWF","ZEAL"],"gpt_icon":0},{"id":"2438233678","title":"ZEAL NETWORK SE :Peter Steiner, Chairman Of The Supervisory Board Will Step Down From His Position At 2025 Agm.","url":"https://stock-news.laohu8.com/highlight/detail?id=2438233678","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2438233678?lang=en_us&edition=fundamental","pubTime":"2024-05-27 23:39","pubTimestamp":1716824370,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.trkd.thomsonreuters.com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_live","symbols":["BK4139","ZLNWF","ZEAL"],"gpt_icon":0},{"id":"2434026363","title":"Small grounds, world-class players","url":"https://stock-news.laohu8.com/highlight/detail?id=2434026363","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2434026363?lang=en_us&edition=fundamental","pubTime":"2024-05-10 05:15","pubTimestamp":1715289316,"startTime":"0","endTime":"0","summary":"As our Portfolio Managers scour the world looking for superior investments they occasionally find world-class businesses in the world’s smaller economies. Here’s a look at some of the best.The Irish stockmarket – Euronext Dublin- was established in 1793. It’s long history includes booms in bicycle companies  and railroad and canal stocks . By global standards it’s small – listing 35 companies worth just EUR122 billion at the end of 2023. But it’s host to one of the world’s truly great airlines.“In just three decades, Ireland has transformed from one of the poorest countries in Europe to having the third-highest GDP per capita in the world.“ -Source: Small countries: The way to resilience Credit Suisse Research Institute, 2023. Ryanair is an ultra low-cost carrier headquartered in Swords, Dublin. It’s the third largest airline in the world by passenger volume and its 558 aircraft transport over 180 million people annually .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/small-grounds-world-class-players","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/small-grounds-world-class-players","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["LU1201861165.SGD","BK4588","BK4139","BK4500","BK4548","BK4551","BA","BK4566","LU0130103400.USD","BK4585","LU1435385759.SGD","BK4532","RYAAY","BK4516","BK4187","BK4008","BK4564","LU0648000940.SGD","ZEAL","LU1429558221.USD","LU2326559502.SGD"],"gpt_icon":0},{"id":"2423727399","title":"Total number of shares and voting rights in Zealand Pharma at March 31, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2423727399","media":"StreetInsider","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2423727399?lang=en_us&edition=fundamental","pubTime":"2024-03-31 23:00","pubTimestamp":1711897200,"startTime":"0","endTime":"0","summary":"Company announcement – No. 21 / 2024 Total number of shares and voting rights in Zealand Pharma at March 31, 2024 Copenhagen, Denmark, March 31, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (C","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.streetinsider.com/dr/news.php?id=23002556","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_streetinsider","symbols":["ZEAL","TSS","BK4139"],"gpt_icon":0},{"id":"2422806620","title":"Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons","url":"https://stock-news.laohu8.com/highlight/detail?id=2422806620","media":"StreetInsider","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2422806620?lang=en_us&edition=fundamental","pubTime":"2024-03-27 05:05","pubTimestamp":1711487100,"startTime":"0","endTime":"0","summary":"Attachment. 26032024-Sale of Shares","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.streetinsider.com/dr/news.php?id=22981566","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_streetinsider","symbols":["ZEAL","BK4139"],"gpt_icon":0},{"id":"2422620856","title":"Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2422620856","media":"StreetInsider","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2422620856?lang=en_us&edition=fundamental","pubTime":"2024-03-27 05:00","pubTimestamp":1711486800,"startTime":"0","endTime":"0","summary":"Company announcement – No. 19 / 2024 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark, March 26, 2024 – Zealand Pharma A/S (“Zealand”) (","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.streetinsider.com/dr/news.php?id=22981485","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_streetinsider","symbols":["BK4139","ZEAL"],"gpt_icon":0},{"id":"2421773820","title":"Zealand Pharma's Annual General Meeting 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2421773820","media":"StreetInsider","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2421773820?lang=en_us&edition=fundamental","pubTime":"2024-03-21 00:40","pubTimestamp":1710952800,"startTime":"0","endTime":"0","summary":"Company announcement – No. 17 / 2024 Zealand Pharma's Annual General Meeting 2024 Copenhagen, March 20, 2024 - Today, Zealand Pharma A/S (\"Zealand\") (NASDAQ: ZEAL) (CVR no. 20 04 50 78), held its Annu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.streetinsider.com/dr/news.php?id=22957037","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_streetinsider","symbols":["ZEAL","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zealandpharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0126},{"period":"1month","weight":0.0032},{"period":"3month","weight":0.0263},{"period":"6month","weight":0.0771},{"period":"1year","weight":0.2681},{"period":"ytd","weight":0.1811}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Zealand Pharma A/S, a biotechnology company, engages in the discovery, design, and development of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company markets lixisenatide under the brand names of Adlyxin, Lyxumia, Soliqua 100/33, and Suliqua. Its product pipeline includes Dasiglucagon single use syringe or autoinjector that has completed Phase III clinical trials for the treatment of severe hypoglycemia; Dasiglucagon dual-hormone artificial pancreas has completed Phase II clinical trials for automated diabetes management; Dasiglucagon that is in Phase III clinical trials for congenital hyperinsulinism and in Phase II clinical trials for post bariatric surgery hypoglycemia. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S has collaboration agreements with Sanofi-Aventis Deutschland GmbH; Boehringer Ingelheim International GmbH; Alexion; and Beta Bionics, Inc. The company was founded in 1997 and is headquartered in Copenhagen, Denmark.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.093913},{"month":2,"riseRate":0.4,"avgChangeRate":-0.05145},{"month":3,"riseRate":0.4,"avgChangeRate":0.000758},{"month":4,"riseRate":0.6,"avgChangeRate":-0.002428},{"month":5,"riseRate":0.6,"avgChangeRate":0.073086},{"month":6,"riseRate":0.2,"avgChangeRate":-0.078136},{"month":7,"riseRate":0.8,"avgChangeRate":0.101088},{"month":8,"riseRate":0.8,"avgChangeRate":0.02043},{"month":9,"riseRate":0.666667,"avgChangeRate":0.064338},{"month":10,"riseRate":0.4,"avgChangeRate":-0.027565},{"month":11,"riseRate":0.6,"avgChangeRate":-0.068566},{"month":12,"riseRate":0.4,"avgChangeRate":-0.027197}],"exchange":"NASDAQ","name":"Zealand Pharma A/S","nameEN":"Zealand Pharma A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zealand Pharma A/S(ZEAL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Zealand Pharma A/S(ZEAL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Zealand Pharma A/S,ZEAL,Zealand Pharma A/S股票,Zealand Pharma A/S股票老虎,Zealand Pharma A/S股票老虎国际,Zealand Pharma A/S行情,Zealand Pharma A/S股票行情,Zealand Pharma A/S股价,Zealand Pharma A/S股市,Zealand Pharma A/S股票价格,Zealand Pharma A/S股票交易,Zealand Pharma A/S股票购买,Zealand Pharma A/S股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zealand Pharma A/S(ZEAL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Zealand Pharma A/S(ZEAL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction